Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Fluorescein Tyramide for Sensitive Neural IHC
2026-08-27
Fluorescein Tyramide uses tyramide signal amplification to reveal low-abundance targets in neural-tissue IHC, ISH, and carefully validated flow workflows. This guide connects practical assay design and troubleshooting with oxytocin-circuit findings from a recent early-life-adversity study.
Gramine and the CUL3–MTDH Ferroptosis Axis
2026-08-27
The reference study identifies Gramine as a selective inhibitor of triple-negative breast cancer models and links its activity to CUL3-mediated regulation of MTDH and ferroptosis. Its integrated chemical-proteomic, biochemical, cellular, and xenograft strategy provides a mechanistic framework for studying ferroptosis in cancer biology research while leaving pharmacological and clinical questions unresolved.
MRSA EVs Drive IL-8–Dependent OSCC Growth
2026-08-26
A 2026 Journal of Advanced Research study shows that extracellular vesicles released by methicillin-resistant Staphylococcus aureus can actively promote oral squamous cell carcinoma proliferation through an IL-8–CXCR1 signaling relay. By combining MRSA-versus-MSSA vesicle comparisons, pathway analysis, genetic validation, receptor blockade, and mouse tumor experiments, the work connects antibiotic resistance with tumor-promoting intercellular communication.
Influenza Hemagglutinin (HA) Peptide Workflow
2026-08-26
Use the Influenza Hemagglutinin (HA) Peptide as a practical competitive-elution tool for recovering HA-tagged proteins and preserving interaction-focused samples. This guide connects reproducible immunoprecipitation with Anti-HA antibody workflows to mechanistic protein studies inspired by NEDD4L–PRMT5 signaling research.
Ivermectin: From Parasite Biology to Assay Design
2026-08-25
Ivermectin is a broad-spectrum anti-parasitic research compound whose value depends on rigorous mechanism-based assay design. This guide connects parasite neuromuscular pharmacology, compound handling, and lessons from a seminal GSDMC study without overstating cross-domain evidence.
PH Exercise Capacity Before Skeletal Muscle Dysfunction
2026-08-25
This study separates cardiopulmonary limitations from intrinsic skeletal muscle dysfunction in rat models of pulmonary hypertension induced with SU5416 and hypoxia. Its graded, strain-aware design shows that exercise capacity can fall before measurable defects in muscle force, mitochondrial respiration, or fatigue resistance, helping refine how preclinical exercise intolerance is interpreted.
Synthetic Efferocytic Microglia for Alzheimer’s Disease
2026-08-24
Shao and colleagues engineered a synthetic efferocytic receptor that redirects microglia toward amyloid-β clearance while limiting inflammatory signaling. Delivered through microglia-editing mRNA lipid nanoparticles, the receptor improved pathology-associated and behavioral outcomes in an Alzheimer’s disease mouse model, while also reducing synapse loss.
Amikacin Sulfate: Intracellular Assays and Delivery
2026-08-24
Amikacin Sulfate supports a practical workflow spanning antimicrobial susceptibility, intracellular uptake, and granuloma-focused delivery studies. This guide separates product-backed observations from recommended assay conditions and uses KR-12 peptide research to sharpen endpoint selection without overstating cross-platform evidence.
Calpain Inhibitor II, ALLM: Protease Biology
2026-08-23
Calpain Inhibitor II, ALLM is a cell-permeable peptide inhibitor of calpain I, calpain II, cathepsin L, and cathepsin B. Its reported activity in human leukemia and lymphoma models supports apoptosis-focused experiments, while recent TNBC research defines a separate calpain-2–FAK regulatory context.
Mechanical Stress, Cytoskeleton, and Autophagy
2026-08-22
The study shows that compression-induced autophagy depends primarily on cytoskeletal microfilaments, while microtubules provide a supporting rather than dominant function. Its combination of mechanical stimulation, cytoskeletal polymerization perturbation, fluorescence imaging, and western blotting offers a practical framework for dissecting force-sensitive autophagy in human cells.
DNA Frameworks Improve Enzymatic Oligonucleotide Synthesis
2026-08-21
Li and colleagues developed a tetrahedral DNA nanostructure interface that organizes primers for more accessible and efficient enzymatic oligonucleotide synthesis. The framework improved substrate affinity, reaction kinetics, sequence yield, and deletion-error control, and supported a 60-nucleotide DNA information-storage demonstration.
TAK-242 Workflow for TLR4 Inflammation Studies
2026-08-20
TAK-242 (Resatorvid) gives researchers a selective way to test whether TLR4 drives cytokine release, autophagy, or neuroinflammatory responses. This practical workflow connects LPS benchmark assays with pathogen-derived stimuli while emphasizing solvent control, timing, and orthogonal readouts.
Imipenem Workflows for Antibacterial Research
2026-08-20
Imipenem supports complementary bacterial susceptibility, resistance-selection, immune-response, and sepsis animal model workflows from one broad-spectrum research reagent. This guide translates its PBP-directed activity into practical assay design, preparation controls, and troubleshooting strategies while keeping cross-study comparisons scientifically bounded.
BMS-345541 Hydrochloride: Mapping IKK–RIPK1
2026-08-19
Explore how the IKK inhibitor BMS-345541 hydrochloride can distinguish NF-κB transcriptional control from RIPK1-driven cell death. This mechanistic framework supports more informative inflammation research and apoptosis induction in T-ALL assays.
Gemcitabine HCl in MRI-Guided PDAC Research
2026-08-19
Gemcitabine HCl offers a direct mechanistic anchor for DNA replication inhibition and apoptosis induction in pancreatic cancer models. When paired with longitudinal, multianimal MRI, it supports a more efficient translational workflow that connects in vitro cytotoxicity testing with tumor growth suppression and treatment-response measurement.
8709 records 8/581 page Previous Next First page 上5页 678910 下5页 Last page